Episode 69 - Nolan Townsend - CEO of Lexeo Therapeutics episode artwork

EPISODE · Sep 18, 2025 · 33 MIN

Episode 69 - Nolan Townsend - CEO of Lexeo Therapeutics

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

Welcome back to another episode of The BioHub, we were thrilled to welcome on Nolan Townsend, CEO of Lexeo Therapeutics.Nolan has been at the helm of Lexeo since January 2020, leading a clinical-stage genetic medicine company aiming to transform treatment for genetically-defined cardiovascular diseases and APOE4-associated Alzheimer’s disease. Under his leadership, Lexeo has built a pipeline of therapies rooted in breakthrough science, partnered with prominent academic institutions like Weill Cornell Medicine, and raised significant capital to support its mission. Before Lexeo, Nolan spent more than a decade at Pfizer, where he was President of Pfizer Rare Disease for North America, and also President for its International Rare Disease operations — overseeing strategy, cross-functional teams, and large operating budgets.

Welcome back to another episode of The BioHub, we were thrilled to welcome on Nolan Townsend, CEO of Lexeo Therapeutics.Nolan has been at the helm of Lexeo since January 2020, leading a clinical-stage genetic medicine company aiming to transform treatment for genetically-defined cardiovascular diseases and APOE4-associated Alzheimer’s disease. Under his leadership, Lexeo has built a pipeline of therapies rooted in breakthrough science, partnered with prominent academic institutions like Weill Cornell Medicine, and raised significant capital to support its mission. Before Lexeo, Nolan spent more than a decade at Pfizer, where he was President of Pfizer Rare Disease for North America, and also President for its International Rare Disease operations — overseeing strategy, cross-functional teams, and large operating budgets.

NOW PLAYING

Episode 69 - Nolan Townsend - CEO of Lexeo Therapeutics

0:00 33:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 33 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on September 18, 2025.

What is this episode about?

Welcome back to another episode of The BioHub, we were thrilled to welcome on Nolan Townsend, CEO of Lexeo Therapeutics.Nolan has been at the helm of Lexeo since January 2020, leading a clinical-stage genetic medicine company aiming to transform...

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!